摩根士丹利:中国工商银行_风险回报更新


摩根大通· 2024-10-14 14:30
Investment Rating - The investment rating for Industrial and Commercial Bank of China (ICBC) is "Overweight" with a price target of HK$5.60 [1][3][11]. Core Viewpoints - The report indicates that ICBC is well-positioned for earnings growth due to strong balance sheet liquidity and a healthy net interest income growth trend [2][5]. - The earnings forecast has been revised down due to expected net interest margin (NIM) contraction influenced by mortgage rate cuts and LPR cuts, leading to a net profit growth forecast of -2.2% in 2024 [1][4]. - The report maintains a long-term view on the bank's performance despite recent pressures, with a focus on fintech investments to improve efficiency [3][5]. Summary by Sections Earnings Forecast - The net interest margin is projected to decrease to 1.40% in 2024, 1.36% in 2025, and 1.39% in 2026 [4]. - Total asset growth is expected to be 7.7% in 2024, 5.7% in 2025, and 5.7% in 2026 [4]. - The cost-income ratio is forecasted to remain stable around 32.3% in 2024 [4]. Investment Drivers - A good balance sheet mix and growth trend are expected to support healthy net interest income growth [5]. - Efficiency improvements from fintech investments are anticipated to enhance pricing capability [5]. Risk and Reward Analysis - The report outlines a bull case price target of HK$8.30, a base case of HK$5.87, and a bear case of HK$2.03 [3][4]. - The implied probabilities for reaching the price targets are 12.3% for HK$5.60 and 0.2% for HK$8.30 [3]. Valuation Methodology - The valuation is based on a three-stage dividend discount model with a discount rate of 10.5% in the base case [6].
摩根士丹利:汽车及汽车零部件_与比亚迪日本汽车公司小组会议的要点


汽车之家· 2024-10-14 14:30
Battery). October 10, 2024 02:56 AM GMT M Update Autos & Auto Parts | Japan | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
摩根士丹利:顺丰控股_拟议中期及特别股息
摩根大通· 2024-10-14 14:30AI Processing
Investment Rating - The investment rating for S.F. Holding Co Ltd is "Equal-weight" with a price target of Rmb40.60, indicating a downside of approximately 3% from the current price of Rmb41.65 as of October 10, 2024 [4][17]. Core Insights - S.F. Holding Co Ltd has proposed an interim dividend of Rmb0.4 per share, representing a 40% payout ratio for the first half of 2024, an increase from 35% in 2023. Additionally, a special dividend of Rmb1 per share is planned before the Hong Kong listing, totaling Rmb4.8 billion, which implies a yield of 2.4% based on the latest closing price [2]. - The company has also executed share buybacks amounting to Rmb1 billion in the first phase and Rmb758 million in the second phase, which could provide an additional 0.9% return to shareholders if fully canceled [2]. Financial Metrics Summary - For the fiscal year ending December 2023, the estimated revenue is Rmb258,409 million, with projected growth to Rmb286,643 million in 2024 and Rmb304,883 million in 2025 [4]. - The earnings per share (EPS) is projected to increase from Rmb1.47 in 2023 to Rmb1.84 in 2024, and further to Rmb2.08 in 2025 [4]. - The company’s P/E ratio is expected to decrease from 27.5 in 2023 to 22.6 in 2024, indicating improved valuation metrics [4]. - The dividend yield is projected to rise from 1.5% in 2023 to 2.0% in 2024, and further to 2.4% in 2025 [4].
摩根士丹利:中信银行-风险回报更新

摩根大通· 2024-10-14 14:30
Investment Rating - The investment rating for China CITIC Bank Corporation Limited is Equal-weight with a price target of HK$4.50 [1][2]. Core Insights - The report indicates stable business growth with an improved risk profile and business restructuring for China CITIC Bank [2]. - Earnings forecasts have been revised following the 2Q24 results, with net interest margin (NIM) forecasts adjusted to 1.76% for 2024, 1.74% for 2025, and 1.78% for 2026 [1]. - Loan growth and deposit growth forecasts have been revised down to 3.5%/3.1%/3.1% and 3.6%/3.4%/3.4% for 2024/25/26 respectively, while non-performing loan (NPL) ratio forecasts have been slightly increased to 1.19%/1.21%/1.27% for the same period [1]. - The bank is expected to deliver net profit growth of 1.2% in 2024, 3.3% in 2025, and 7.7% in 2026, with EPS estimates adjusted down by 0.5%/0.8% for 2024/25 and up by 1.8% for 2026 [1]. Summary by Sections Earnings Inputs - Net interest margin is projected at 1.76% for 2024, total asset growth at 2.9%, credit cost at 1.05%, and cost-income ratio at 33.3% [5][6]. Investment Drivers - The report highlights gradual improvement in asset quality and cooperation within the Citic Group as key investment drivers [7]. - The bank's focus on innovative online products and stable business growth are also noted as positive factors [7]. Price Target and Valuation - The price target of HK$4.50 is derived using a dividend discount model (DDM) based on long-term dividend forecasts [2][3]. - The report indicates a consensus price target distribution with a mean target of HK$4.47 and a maximum of HK$7.45 [3].
摩根士丹利:杭州银行_风险回报更新
杭州路过网络· 2024-10-14 14:30
Investment Rating - The investment rating for Bank of Hangzhou Co Ltd is Equal-weight with a price target of Rmb13.20 [1][3]. Core Insights - The report indicates significant local economic advantages for Bank of Hangzhou, but notes that the transition to retail banking may take time [2]. - Earnings forecasts have been revised down due to the impact of mortgage rate cuts and LPR cuts on the bank's net interest margin (NIM), which is projected to be 1.4% for 2024 [1][5]. - Loan growth forecasts have been raised to 15.3% for 2024, reflecting the bank's rapid expansion in the first half of 2024 [1]. - The report anticipates an increase in the non-performing loan (NPL) formation ratio to 0.50% in 2024, with a corresponding NPL ratio forecast of 0.78% [1]. Summary by Sections Earnings Forecasts - The net profit growth forecasts have been revised down to 10.6% for 2024, 6.3% for 2025, and 10.9% for 2026 [1]. - The earnings per share (EPS) estimates have been slightly revised up for 2024 by 0.51%, while estimates for 2025 and 2026 have been revised down by 3.49% and 3.39% respectively [1]. Key Earnings Inputs - The net interest margin is projected to decrease from 1.50% in 2023 to 1.40% in 2024, and further to 1.38% in 2025 and 1.41% in 2026 [5][6]. - Total asset growth is expected to decline from 13.9% in 2023 to 11.8% in 2024 [5]. - Credit costs are anticipated to rise from 0.72% in 2023 to 0.94% in 2024 [5]. Risk Reward Analysis - The report highlights a low-risk strategy focusing on corporate and retail loans with high asset quality [3]. - It notes that the bank faces competition from major national banks, which could impact its funding costs and NIM [3].
摩根士丹利:东阿阿胶_研究战术理念
摩根大通· 2024-10-14 14:30
M Idea Sound Bites | Asia Pacific October 10, 2024 11:59 AM GMT Dong E E Jiao Co.: Research Tactical Idea DEEJ's preliminary earnings range for 3Q2024 was a strong beat. In our view, these results should dispel fears in the investment community since May that a weak consumption economy and a tight government insurance budget would hamper DEEJ's performance. Key Takeaways We think a 43% to 73% YoY net profit growth range will very likely lead consensus estimates for the full year to rise... …making short-ter ...
摩根士丹利:华海药业2024 年第三季度初步业绩预测 - 重申为首选
摩根大通· 2024-10-14 14:30
Investment Rating - The report assigns an "Overweight" rating to Zhejiang Huahai Pharmaceutical Co. Ltd. with a price target of Rmb22.00, indicating a potential upside of 15% from the current price of Rmb19.20 [5]. Core Insights - The strong performance of Huahai is attributed to market share gains, gross margin expansion due to a change in product mix, and successful product launches [3]. - The China formulation segment has shown the best performance, followed by API exports and US formulations [3]. - The report highlights a significant growth inflection in China's pharmaceutical export sector since May 2024, following a prolonged de-stocking cycle post-COVID-19 [3]. - The investment thesis is based on three observations: the beginning of an up-cycle in China's API industry, successful forward integration by Huahai leading to margin stabilization and expansion, and a low profit base in 2023 [3]. Financial Summary - Huahai reported a net profit range of Rmb239 million to Rmb297 million for 3Q2024, reflecting a year-over-year increase of 57% to 95% [2]. - Revenue projections for the fiscal years ending December 2023 to December 2026 are Rmb8,309 million, Rmb9,820 million, Rmb11,055 million, and Rmb12,341 million respectively [6]. - The expected EPS for the same period is projected to grow from Rmb0.57 in 2023 to Rmb1.23 in 2026 [6]. - The report indicates a P/E ratio decreasing from 25.7 in 2023 to 15.6 in 2026, suggesting improving valuation metrics over time [6].
摩根士丹利:韦尔股份_3Q24 业绩超出预期,得益于手机和汽车中采用的更多传感器;OW
汽车之家· 2024-10-14 14:30
Investment Rating - The investment rating for Will Semiconductor Co Ltd is Overweight (OW) [4][3]. Core Viewpoints - Will Semiconductor reported solid earnings growth for 3Q24, with a preliminary net income range of Rmb0.9-1.1 billion, indicating a 24% quarter-over-quarter increase at the mid-point [2]. - The revenue for 3Q24 is estimated to be between Rmb6.65-6.9 billion, reflecting a 5% quarter-over-quarter growth, attributed to the rising adoption of high-end smartphone camera image sensors (CIS) and increased penetration in automotive CIS [2][3]. - The company is expected to further expand its market share in the smartphone and automotive CIS sectors, with anticipated improvements in margins and earnings due to a better product mix [3]. Financial Metrics Summary - Price Target: Rmb120.00 [4] - Current Share Price (as of October 9, 2024): Rmb115.48 [4] - Market Capitalization: Rmb140.32 billion [4] - Revenue Forecasts: - FY 2023: Rmb21.021 billion - FY 2024e: Rmb26.184 billion - FY 2025e: Rmb31.800 billion - FY 2026e: Rmb35.385 billion [4] - EPS Forecasts: - FY 2023: Rmb0.47 - FY 2024e: Rmb2.65 - FY 2025e: Rmb3.93 - FY 2026e: Rmb4.50 [4] - EBITDA Forecasts: - FY 2023: Rmb2.281 billion - FY 2024e: Rmb4.389 billion - FY 2025e: Rmb6.401 billion - FY 2026e: Rmb7.293 billion [4] - P/E Ratio: - FY 2023: 228.5 - FY 2024e: 43.6 - FY 2025e: 29.4 - FY 2026e: 25.7 [4] - ROE: - FY 2023: 3.1% - FY 2024e: 15.0% - FY 2025e: 19.4% - FY 2026e: 19.0% [4]
摩根士丹利:中国银行股份有限公司_风险回报更新


摩根大通· 2024-10-14 14:30
Investment Rating - The investment rating for Bank of China Limited is Equal-weight [1][2][11]. Core Views - The report indicates that while there is good progress in the business transition of Bank of China, its valuation is less attractive compared to its Hong Kong counterpart [2][3]. - The earnings forecasts for Bank of China have been revised downwards due to the impact of mortgage rate cuts and LPR cuts, leading to a projected net interest margin (NIM) contraction [1][4]. - The report maintains a long-term view on the bank's performance, with a price target derived from a dividend discount model (DDM) remaining unchanged [1][4]. Summary by Sections Earnings Forecasts - EPS forecasts for Bank of China are adjusted to 0.74, 0.75, and 0.76 RMB for fiscal years 2024, 2025, and 2026 respectively [1]. - NIM forecasts have been revised to 1.42%, 1.36%, and 1.39% for 2024, 2025, and 2026 [4]. - The net profit growth forecasts are lowered to 0.5%, 0.4%, and 1.6% for 2024, 2025, and 2026 [1]. Key Drivers - The report highlights the drivers of growth for Bank of China, including the transition towards wealth management and asset management amid business reforms [5]. - Total asset growth is projected at 12.2% for 2023, decreasing to 6.4% in 2024 and stabilizing at 6.1% for 2025 and 2026 [4]. Risk and Reward Analysis - The risk-reward analysis indicates a positive outlook for Bank of China, despite the challenges posed by external economic factors [3][5]. - The consensus price target distribution shows a mean target of 4.20 RMB, with Morgan Stanley's price target at 4.50 RMB [3].
摩根士丹利:中国农业银行_风险回报更新


摩根大通· 2024-10-14 14:30
Investment Rating - The investment rating for Agricultural Bank of China Limited is Overweight [1][3]. Core Views - The report highlights a play on the government's economic rebalancing, with continuously improving asset quality and the highest NPL coverage ratio among the Big 5 banks [5]. - The bank has a strong deposit franchise, particularly in rural areas, leading to a stable funding structure, with deposits accounting for 78% of total liabilities in FY2023 [5]. - The valuation is attractive, with a projected 2024E dividend yield of 7.7%, compared to 5.3% for ABC-A [5]. Earnings Forecasts - Earnings forecasts for Agricultural Bank of China Limited have been revised following 2Q24 results, with net interest margin (NIM) forecasts adjusted to 1.43%/1.39%/1.42% for 2024/25/26 [1]. - Loan growth estimates have been raised to 9.2%/7.7%/6.3% for the same periods, leading to higher net interest income growth forecasts of 2.3%/5.1%/9.6% in 2024/25/26 [1]. - Net profit forecasts have been slightly revised up to 2.2%/2.7%/2.5% for 2024/25/26, with EPS estimates increased by 1.1%/1.1%/0.7% for the same years [1]. Price Target and Valuation - The price target for Agricultural Bank of China Limited is set at HK$4.40, with a bull case price target of HK$6.59 and a bear case of HK$1.55 [3][4]. - The report employs a three-stage dividend discount model with a probability-weighted approach, assigning 60% to the base case, 20% to the bull case, and 20% to the bear case [6]. Risk Reward Themes - The risk-reward chart indicates a 94% Overweight rating, with 0% Equal-weight and 6% Underweight [6]. - Key themes include pricing power being negative, with various scenarios outlined for bull, base, and bear cases reflecting different economic conditions [6][7].